Viewing StudyNCT00041613



Ignite Creation Date: 2024-05-05 @ 11:26 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00041613
Status: UNKNOWN
Last Update Posted: 2008-04-01
First Post: 2002-07-11

Brief Title: Study to Compare the Overall Survival of Patients Receiving INGN 201 Study Drug With Patients Receiving Methotrexate
Sponsor: Introgen Therapeutics
Organization: Introgen Therapeutics

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: None
Completion Date Type: None
First Submit Date: 2002-07-11
First Submit QC Date: July 11 2002
Study First Post Date: 2002-07-12
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2008-03-28
Last Update Post Date: 2008-04-01
Last Update Post Date Type: ESTIMATED